A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke

Terminated

Phase 2 Results N/A

Main Contacts

Name Phone E-mail
Pfizer CT.gov Call Center Study Director

Other Locations

Name City State Country Status
Pfizer Investigational Site Fort Wayne Indiana United States Unknown_status_icon
Pfizer Investigational Site Leipzig Germany Unknown_status_icon
Pfizer Investigational Site La Mesa California United States Unknown_status_icon
Pfizer Investigational Site Atlanta Georgia United States Unknown_status_icon
Pfizer Investigational Site Fort Wayne Indiana United States Unknown_status_icon
Pfizer Investigational Site Louisville Kentucky United States Unknown_status_icon
Pfizer Investigational Site Louisville, Kentucky United States Unknown_status_icon
Pfizer Investigational Site Salisbury North Carolina United States Unknown_status_icon
Pfizer Investigational Site Dayton Ohio United States Unknown_status_icon
Pfizer Investigational Site Dayton Ohio United States Unknown_status_icon
Pfizer Investigational Site Dayton Ohio United States Unknown_status_icon
Pfizer Investigational Site Dayton Ohio United States Unknown_status_icon
Pfizer Investigational Site Allentown Pennsylvania United States Unknown_status_icon
Pfizer Investigational Site Philadelphia Pennsylvania United States Unknown_status_icon
Pfizer Investigational Site Tartu Estonia Unknown_status_icon
Pfizer Investigational Site Bad Neustadt Germany Unknown_status_icon
Pfizer Investigational Site Freiburg Germany Unknown_status_icon
Pfizer Investigational Site Luebeck Germany Unknown_status_icon
Pfizer Investigational Site Budapest Hungary Unknown_status_icon
Pfizer Investigational Site Gyor Hungary Unknown_status_icon
Pfizer Investigational Site Pavia Italy Unknown_status_icon
Pfizer Investigational Site Perugia Italy Unknown_status_icon
Pfizer Investigational Site Coimbra Portugal Unknown_status_icon
Pfizer Investigational Site Lisboa Portugal Unknown_status_icon
Pfizer Investigational Site Singapore Singapore Unknown_status_icon
Pfizer Investigational Site Singapore Singapore Unknown_status_icon
Pfizer Investigational Site Santiago de Compostela Galicia Spain Unknown_status_icon
Pfizer Investigational Site Madrid Spain Unknown_status_icon
Pfizer Investigational Site Madrid Spain Unknown_status_icon
Pfizer Investigational Site Zaragoza Spain Unknown_status_icon